Erratum to: Environ Health Prev Med DOI 10.1007/s12199-016-0514-6
Unfortunately, the bold values of Tables 4, 5, 6 and 7 were published incorrectly in the original publication of the article and are corrected with this erratum.
Table 4.
Results of multiple linear regression analysis of the SF-36 scores: physical functioning (PF), role physical (RP), bodily pain (BP), and general health (GH), among men of Group 2
| Explanatory variables | PF | RP | BP | GH | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| B | (95 % CI) | β | B | (95 % CI) | β | B | (95 % CI) | β | B | (95 % CI) | β | |
| Constant | 106.9 | (95.4, 118.4)*** | 105.4 | (91.6, 119.2)*** | 85.1 | (66.2, 104.0)*** | 57.6 | (43.7, 71.6)*** | ||||
| Age | −0.189 | (−0.401, 0.022) | −0.108 | −0.041 | (−0.295, 0.213) | −0.020 | 0.071 | (−0.277, 0.418) | 0.023 | 0.151 | (−0.106, 0.407) | 0.069 |
| Obesity | ||||||||||||
| BMI <25.0a | ||||||||||||
| BMI ≥25.0 | −4.89 | (−8.13, −1.65) | −0.170** | −3.60 | (−7.49, 0.286) | −0.106 | −5.85 | (−11.2, −0.526) | −0.116* | 0.283 | (−3.65, 4.21) | 0.008 |
| Hypertension | ||||||||||||
| Noa | ||||||||||||
| Yes | 0.424 | (−3.02, 3.87) | 0.014 | 2.87 | (−1.27, 7.00) | 0.079 | 3.03 | (−2.63, 8.70) | 0.056 | −2.71 | (−6.89, 1.47) | −0.071 |
| Diabetes mellitus | ||||||||||||
| Noa | ||||||||||||
| Yes | −0.429 | (−5.47, 4.61) | −0.009 | −1.85 | (−7.90, 4.20) | −0.035 | 5.53 | (−2.76, 13.8) | 0.070 | −10.5 | (−16.6, −4.35) | −0.186** |
| Allergic disease | ||||||||||||
| Noa | ||||||||||||
| Yes | 1.88 | (−3.08, 6.84) | 0.043 | 1.60 | (−4.36, 7.56) | 0.031 | 2.60 | (−5.56, 10.8) | 0.033 | 0.864 | (−5.16, 6.89) | 0.016 |
| Cancer | ||||||||||||
| Noa | ||||||||||||
| Yes | −6.94 | (−18.6, 4.72) | −0.066 | −17.9 | (−31.9, −3.89) | −0.145* | −8.30 | (−27.5, 10.9) | −0.045 | −17.6 | (−31.8, −3.46) | −0.135* |
| Insomnia and depression | ||||||||||||
| Noa | ||||||||||||
| Yes | −7.39 | (−17.2, 2.40) | −0.083 | −1.22 | (−13.0, 10.5) | −0.012 | 1.31 | (−14.8, 17.4) | 0.008 | −17.8 | (−29.7, −5.92) | −0.162** |
| Chronic pain | ||||||||||||
| Noa | ||||||||||||
| Yes | −5.45 | (−8.73, −2.16) | −0.187** | −5.08 | (−9.02, −1.13) | −0.148* | −19.6 | (−25.0, −14.2) | −0.385*** | −6.51 | (−10.5, −2.52) | −0.180** |
| Occupational status | ||||||||||||
| Employeda | ||||||||||||
| Unemployed | 0.136 | (−4.12, 4.39) | 0.004 | −5.46 | (−10.6, −0.353) | −0.126* | −1.06 | (−8.06, 5.94) | −0.016 | 1.06 | (−4.11, 6.23) | 0.023 |
| Sleep condition | ||||||||||||
| Good sleepa | ||||||||||||
| Poor sleep | −2.63 | (−5.66, 0.398) | −0.099 | −2.52 | (−6.16, 1.11) | −0.080 | −8.89 | (−13.9, −3.91) | −0.190** | −6.55 | (−10.2, −2.87) | −0.197** |
| Frequency of exercise | ||||||||||||
| More than 1−2 times a weeka | ||||||||||||
| Never | −3.40 | (−6.42, −0.378) | −0.127* | −1.55 | (−5.18, 2.07) | −0.049 | −0.877 | (−5.85, 4.09) | −0.019 | 1.13 | (−2.54, 4.80) | 0.034 |
| Number of observations | 302 | 302 | 302 | 302 | ||||||||
| R 2 | 0.132 | 0.103 | 0.238 | 0.174 | ||||||||
| Adjusted R 2 | 0.099 | 0.069 | 0.209 | 0.143 | ||||||||
| F | 4.011 | 3.014 | 8.216 | 5.568 | ||||||||
| Significant F | 0.000 | 0.001 | 0.000 | 0.000 | ||||||||
B unstandardized coefficients, β standardized coefficients
Bold values indicate p < 0.05
aReference group, * p < 0.05, ** p < 0.01, *** p < 0.001
Table 5.
Results of multiple linear regression analysis of the SF-36 scores: vitality (VT), social functioning (SF), role emotional (RE), and mental health (MH) among men of Group 2
| Explanatory variables | VT | SF | RE | MH | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| B | (95 % CI) | β | B | (95 % CI) | β | B | (95 % CI) | β | B | (95 % CI) | β | |
| Constant | 43.6 | (27.5, 59.7)*** | 99.9 | (85.4, 114.5)*** | 107.5 | (93.1, 121.9)*** | 59.3 | (44.8, 73.7)*** | ||||
| Age | 0.578 | (0.282, 0.874) | 0.222*** | 0.029 | (−0.238, 0.297) | 0.013 | −0.022 | (−0.286, 0.242) | −0.010 | 0.381 | (0.115, 0.647) | 0.174** |
| Obesity | ||||||||||||
| BMI <25.0a | ||||||||||||
| BMI ≥25.0 | −0.809 | (−5.34, 3.72) | −0.019 | −4.37 | (−8.47, −0.277) | −0.123* | −4.35 | (−8.39, −0.315) | −0.124* | 0.768 | (−3.30, 4.84) | 0.021 |
| Hypertension | ||||||||||||
| Noa | ||||||||||||
| Yes | 4.19 | (−0.627, 9.01) | 0.092 | 5.66 | (1.30, 10.0) | 0.149* | 4.09 | (−0.207, 8.39) | 0.109 | 3.11 | (−1.22, 7.44) | 0.081 |
| Diabetes mellitus | ||||||||||||
| Noa | ||||||||||||
| Yes | −0.463 | (−7.51, 6.59) | −0.007 | 0.238 | (−6.14, 6.61) | 0.004 | −2.46 | (−8.75, 3.83) | −0.045 | −1.39 | (−7.73, 4.95) | −0.025 |
| Allergic disease | ||||||||||||
| Noa | ||||||||||||
| Yes | 3.10 | (−3.84, 10.0) | 0.047 | 4.85 | (−1.43, 11.1) | 0.089 | 0.977 | (−5.22, 7.17) | 0.018 | 0.754 | (−5.49, 7.00) | 0.014 |
| Cancer | ||||||||||||
| Noa | ||||||||||||
| Yes | −15.8 | (−32.1, 0.494) | −0.102 | 0.641 | (−14.1, 15.4) | 0.005 | −6.12 | (−20.7, 8.42) | −0.048 | −5.93 | (−20.6, 8.73) | −0.046 |
| Insomnia and depression | ||||||||||||
| Noa | ||||||||||||
| Yes | −9.66 | (−23.4, 4.04) | −0.074 | −10.0 | (−22.4, 2.35) | −0.092 | −2.32 | (−14.5, 9.90) | −0.022 | −7.83 | (−20.1, 4.49) | −0.071 |
| Chronic pain | ||||||||||||
| Noa | ||||||||||||
| Yes | −9.93 | (−14.5, −5.34) | −0.231*** | −1.22 | (−5.38, 2.94) | −0.034 | −3.70 | (−7.80, 0.40) | −0.104 | −5.53 | (−9.66, −1.40) | −0.153** |
| Occupational status | ||||||||||||
| Employeda | ||||||||||||
| Unemployed | 0.025 | (−5.93, 5.98) | 0.000 | −5.63 | (−11.0, −0.244) | −0.124* | −7.79 | (−13.1, −2.48) | −0.174** | −1.01 | (−6.36, 4.35) | −0.022 |
| Sleep condition | ||||||||||||
| Good sleepa | ||||||||||||
| Poor sleep | −7.72 | (−12.0, −3.48) | −0.195*** | −3.26 | (−7.10, 0.568) | −0.099 | −2.36 | (−6.14, 1.42) | −0.072 | −4.87 | (−8.68, −1.06) | −0.146* |
| Frequency of exercise | ||||||||||||
| More than 1−2 times a weeka | ||||||||||||
| Never | −5.33 | (−9.55, −1.10) | −0.134* | −4.14 | (−7.96, −0.313) | −0.125* | −2.74 | (−6.51, 1.04) | −0.084 | −2.81 | (−6.62, 0.988) | −0.084 |
| Number of observations | 302 | 302 | 302 | 302 | ||||||||
| R 2 | 0.227 | 0.094 | 0.092 | 0.117 | ||||||||
| Adjusted R 2 | 0.198 | 0.060 | 0.058 | 0.083 | ||||||||
| F | 7.748 | 2.741 | 2.674 | 3.486 | ||||||||
| Significant F | 0.000 | 0.002 | 0.003 | 0.000 | ||||||||
B unstandardized coefficients, β standardized coefficients
Bold values indicate p < 0.05
aReference group, * p < 0.05, ** p < 0.01, *** p < 0.001
Table 6.
Results of multiple linear regression analysis of the SF-36 scores: physical functioning (PF), role physical (RP), bodily pain (BP), and general health (GH), among women of Group 2
| Explanatory variables | PF | RP | BP | GH | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| B | (95 % CI) | β | B | (95 % CI) | β | B | (95 % CI) | β | B | (95 % CI) | β | |
| Constant | 96.5 | (87.4, 105.5)*** | 96.5 | (84.2, 108.8)*** | 77.1 | (61.4, 92.7)*** | 62.3 | (49.1, 75.6)*** | ||||
| Age | 0.040 | (−0.129, 0.208) | 0.026 | 0.099 | (−0.129, 0.327) | 0.049 | 0.224 | (−0.066, 0.513) | 0.079 | 0.295 | (0.049, 0.541) | 0.128* |
| Obesity | ||||||||||||
| BMI <25.0a | ||||||||||||
| BMI ≥25.0 | −1.14 | (−4.27, 1.99) | −0.038 | −3.23 | (−7.46, 1.01) | −0.080 | 1.73 | (−3.66, 7.12) | 0.030 | −1.54 | (−6.11, 3.04) | −0.033 |
| Hypertension | ||||||||||||
| Noa | ||||||||||||
| Yes | −2.57 | (−5.65, 0.505) | −0.090 | 1.81 | (−2.36, 5.97) | 0.047 | −3.77 | (−9.07, 1.52) | −0.069 | −8.84 | (−13.3, −4.34) | −0.200*** |
| Diabetes mellitus | ||||||||||||
| Noa | ||||||||||||
| Yes | 3.87 | (−1.89, 9.63) | 0.070 | 1.39 | (−6.40, 9.19) | 0.019 | 1.51 | (−8.40, 11.4) | 0.014 | −8.12 | (−16.5, 0.312) | −0.096 |
| Allergic disease | ||||||||||||
| Noa | ||||||||||||
| Yes | −0.991 | (−4.13, 2.15) | −0.033 | 0.665 | (−3.58, 4.91) | 0.016 | 0.624 | (−4.77, 6.02) | 0.011 | −0.615 | (−5.20, 3.97) | −0.013 |
| Cancer | ||||||||||||
| Noa | ||||||||||||
| Yes | −8.72 | (−15.9, −1.57) | −0.127* | −5.12 | (−14.8, 4.55) | −0.055 | −3.32 | (−15.6, 8.99) | −0.025 | −1.24 | (−11.7, 9.22) | −0.012 |
| Insomnia and depression | ||||||||||||
| Noa | ||||||||||||
| Yes | −11.1 | (−19.1, −3.22) | −0.145** | −14.7 | (−25.4, −4.00) | −0.142** | −9.97 | (−23.6, 3.65) | −0.068 | −14.6 | (−26.2, −3.04) | −0.124* |
| Chronic pain | ||||||||||||
| Noa | ||||||||||||
| Yes | −1.48 | (−4.12, 1.16) | −0.058 | −2.07 | (−5.63, 1.50) | −0.060 | −22.6 | (−27.2, −18.1) | −0.469*** | −5.72 | (−9.58, −1.86) | −0.146** |
| Occupational status | ||||||||||||
| Employeda | ||||||||||||
| Unemployed | −2.91 | (−5.77, −0.054) | −0.109* | −4.19 | (−8.06, −0.323) | −0.117* | −2.14 | (−7.06, 2.78) | −0.042 | −5.28 | (−9.46, −1.10) | −0.129* |
| Sleep condition | ||||||||||||
| Good sleepa | ||||||||||||
| Poor sleep | −3.13 | (−5.53, −0.732) | −0.136* | −6.32 | (−9.56, −3.07) | −0.203*** | −4.41 | (−8.53, −0.280) | −0.101* | −8.77 | (−12.3, −5.26) | −0.247*** |
| Frequency of exercise | ||||||||||||
| More than 1−2 times a weeka | ||||||||||||
| Never | −2.36 | (−4.77, 0.061) | −0.101 | −0.520 | (−3.79, 2.75) | −0.017 | −0.626 | (−4.78, 3.53) | −0.014 | −0.970 | (−4.50, 2.57) | −0.027 |
| Number of observations | 348 | 348 | 348 | 348 | ||||||||
| R 2 | 0.100 | 0.094 | 0.261 | 0.189 | ||||||||
| Adjusted R 2 | 0.071 | 0.065 | 0.236 | 0.162 | ||||||||
| F | 3.411 | 3.180 | 10.76 | 7.102 | ||||||||
| Significant F | 0.000 | 0.000 | 0.000 | 0.000 | ||||||||
B unstandardized coefficients, β standardized coefficients
Bold values indicate p < 0.05
aReference group, * p < 0.05, ** p < 0.01, *** p < 0.001
Table 7.
Results of multiple linear regression analysis of the SF-36 scores: vitality (VT), social functioning (SF), role emotional (RE), and mental health (MH) among women of Group 2
| Explanatory variables | VT | SF | RE | MH | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| B | (95 % CI) | β | B | (95 % CI) | β | B | (95 % CI) | β | B | (95 % CI) | β | |
| Constant | 35.1 | (20.6, 49.6)*** | 78.8 | (65.3, 92.4)*** | 85.4 | (72.7, 98.1)*** | 51.2 | (37.9, 64.5)*** | ||||
| Age | 0.718 | (0.450, 0.987) | 0.279*** | 0.275 | (0.023, 0.526) | 0.124* | 0.269 | (0.034, 0.504) | 0.126* | 0.532 | (0.286, 0.778) | 0.231** |
| Obesity | ||||||||||||
| BMI <25.0a | ||||||||||||
| BMI ≥25.0 | 2.81 | (−2.19, 7.81) | 0.054 | 1.99 | (−2.69, 6.66) | 0.045 | −3.03 | (−7.39, 1.34) | −0.071 | 3.31 | (−1.26, 7.89) | 0.072 |
| Hypertension | ||||||||||||
| Noa | ||||||||||||
| Yes | −4.69 | (−9.61, 0.226) | −0.095 | −1.96 | (−6.56, 2.63) | −0.046 | 1.46 | (−2.83, 5.75) | 0.036 | −2.77 | (−7.27, 1.73) | −0.063 |
| Diabetes mellitus | ||||||||||||
| Noa | ||||||||||||
| Yes | 3.37 | (−5.83, 12.6) | 0.036 | 7.04 | (−1.57, 15.6) | 0.087 | −0.798 | (−8.84, 7.24) | −0.010 | −0.440 | (−8.86, 7.98) | −0.005 |
| Allergic disease | ||||||||||||
| Noa | ||||||||||||
| Yes | −1.15 | (−6.16, 3.86) | −0.022 | −0.580 | (−5.26, 4.10) | −0.013 | 0.181 | (−4.19, 4.56) | 0.004 | 1.83 | (−2.75, 6.42) | 0.039 |
| Cancer | ||||||||||||
| Noa | ||||||||||||
| Yes | −1.11 | (−12.5, 10.3) | −0.009 | −0.546 | (−11.2, 10.1) | −0.005 | −3.63 | (−13.6, 6.35) | −0.037 | −0.808 | (−11.3, 9.64) | −0.008 |
| Insomnia and depression | ||||||||||||
| Noa | ||||||||||||
| Yes | −14.0 | (−26.6, −1.32) | −0.106* | −4.91 | (−16.7, 6.91) | −0.043 | −15.9 | (−27.0, −4.89) | −0.146** | −17.8 | (−29.4, −6.26) | −0.152** |
| Chronic pain | ||||||||||||
| Noa | ||||||||||||
| Yes | −10.0 | (−14.2, −5.81) | −0.229*** | −2.95 | (−6.88, 0.991) | −0.079 | −2.69 | (−6.37, 0.985) | −0.075 | −2.32 | (−6.17, 1.53) | −0.060 |
| Occupational status | ||||||||||||
| Employeda | ||||||||||||
| Unemployed | 0.115 | (−4.45, 4.68) | 0.003 | −0.875 | (−5.15, 3.40) | −0.022 | −3.02 | (−7.01, 0.973) | −0.080 | 0.274 | (−3.91, 4.45) | 0.007 |
| Sleep condition | ||||||||||||
| Good sleepa | ||||||||||||
| Poor sleep | −9.46 | (−13.3, −5.63) | −0.239*** | −6.55 | (−10.1, −2.97) | −0.193*** | −9.18 | (−12.5, −5.83) | −0.280*** | −11.3 | (−14.9, −7.84) | −0.321*** |
| Frequency of exercise | ||||||||||||
| More than 1−2 times a weeka | ||||||||||||
| Never | −3.21 | (−7.07, 0.654) | −0.080 | 1.47 | (−2.14, 5.08) | 0.043 | 1.06 | (−2.31, 4.43) | 0.032 | −0.639 | (−4.17, 2.89) | −0.018 |
| Number of observations | 348 | 348 | 348 | 348 | ||||||||
| R 2 | 0.222 | 0.074 | 0.130 | 0.180 | ||||||||
| Adjusted R2 | 0.197 | 0.043 | 0.102 | 0.153 | ||||||||
| F | 8.736 | 2.429 | 4.569 | 6.702 | ||||||||
| Significant F | 0.000 | 0.006 | 0.000 | 0.000 | ||||||||
B unstandardized coefficients, β standardized coefficients
Bold values indicate p < 0.05
aReference group, * p < 0.05, ** p < 0.01, *** p < 0.001
The standardized coefficients “β” values which contain asterisks (*, ** and ***) should be in bold.
Footnotes
The online version of the original article can be found under doi:10.1007/s12199-016-0514-6.
